journal article·2009-02

Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization

Haiying Yu, Pamela J. VandeVord, Li Mao, Howard W. Matthew, Paul H. Wooley, Shang-You Yang

Biomaterials· Volume 30· Issue 4
Publisher page

Abstract

Natural bone growth greatly depends on the precedent vascular network that supplies oxygen and essential nutrients and removes metabolites. Likewise, it is crucial for tissue-engineered bone to establish a vascular network that temporally precedes new bone formation, and spatially originates from within the graft. In order to recapitulate physiological skeletal development, we have developed a complex bone graft to repair rat bone defects. We have demonstrated that endothelial cells and osteoblasts (identified by cell morphology, quantification of specific marker antigens, calcium deposition and capillary-like growth) were able to differentiate and expand from donor rat bone marrow mononuclear cell populations. The biocompatibilities of poly-epsilon-caprolactone (PCL)-hydroxyapatite (HA) composites used for graft fabrication were evaluated at different component ratios to identify the optimal and support of cellular viability and functions for endothelial cells and osteoblasts. Using point-injection and low-pressure techniques, seeded endothelial cells and osteoblasts were able to assemble into microvascular networks and form bony matrix in grafts. The exogenous origination of these cells and their contribution to the vascularization and osteogenesis was confirmed using sex-mismatch implantation and Y chromosome tracking. By pre-seeding with endothelial cells, the resulting vascularization was able to promote osteogenesis, prevent ischemic necrosis and improve the mechanical properties in engineered bone tissue. Taken together, the results indicated that the integration of complex cell populations with composite scaffold materials provided an effective technique to improve osteogenesis in engineered bone graft. These findings suggest that hybrid grafts have great potential for clinical use to treat large bone defects.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. Molecular regulation of vessel maturation10.1038/nm0603-685 ↗
2. Angiogenesis and bone repair10.1016/S1359-6446(03)02866-6 ↗
3. Temporal and spatial increases in blood flow during distraction osteogenesis10.1097/00003086-199404000-00020 ↗
5. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration10.1016/S0008-6363(02)00785-X ↗
6. Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q ↗
7. Natural and synthetic hydroxyapatite filled PCL: mechanical properties and biocompatibility analysis10.1177/0883911504045234 ↗
8. Osteoblast growth and function in porous poly e-caprolactone matrices for bone repair: a preliminary study10.1016/S0142-9612(03)00263-1 ↗
9. Hydroxyapatite/poly(e-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery10.1016/j.biomaterials.2003.07.003 ↗
10. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells10.1002/jor.20609 ↗
11. Effect of porosity and pore size on microstructures and mechanical properties of poly-e-caprolactone-hydroxyapatite composites10.1002/jbm.b.31054 ↗
12. Murine model of prosthesis failure for the long-term study of aseptic loosening10.1002/jor.20342 ↗
13. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke10.1161/01.STR.0000014925.09415.C3 ↗
14. Role of vascular endothelial growth factor in bone marrow stromal cells modulation of endothelial cells10.1089/107632703762687573 ↗
15. Bone marrow stromal cells: characterization and clinical application10.1177/10454411990100020401 ↗
16. Adsorption of vascular endothelial growth factor to two different apatitic materials and its release10.1023/A:1011286818733 ↗
17. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions10.1002/jbm.a.30524 ↗
18. Molecular recognition at the protein-hydroxyapatite interface10.1177/154411130301400507 ↗
19. Application of low-pressure system to sustain in vivo bone formation in osteoblast/porous hydroxyapatite composite
20. The vascular biology of nitric oxide and its role in atherogenesis10.1146/annurev.med.47.1.365 ↗
21. The effects of calcium phosphate particles on the growth of osteoblasts10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N ↗
22. Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats10.1016/j.biomaterials.2004.06.015 ↗
23. Transplantation of cultured bone cells using combinations of scaffolds and culture techniques10.1016/S0142-9612(03)00039-5 ↗
24. Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pretreatment with fibronectin and laminin
25. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep10.1054/ijom.2001.0164 ↗
26. Osteogenesis in in vivo diffusion chamber cultures of human marrow cells
27. Comparison of lumbar spine fusion using mixed and cloned marrow cells10.1097/00007632-200111010-00003 ↗
28. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone10.1016/0142-9612(96)85762-0 ↗